PeproMene Bio anuncia una presentación oral en EHA 2026 donde destacará el PMB-CT01 en linfomas de células B ...Middle East

- PeproMene Bio anuncia una presentación oral en EHA 2026 donde destacará la seguridad favorable y las respuestas duraderas con PMB-CT01 (terapia con células T CAR BAFF-R) en linfomas de células B, incluso después de un fracaso previo de la terapia con células T CAR CD19 IRVINE,...

Hence then, the article about pepromene bio anuncia una presentacion oral en eha 2026 donde destacara el pmb ct01 en linfomas de celulas b was published today ( Friday 29/05/2026 - 08:04 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( PeproMene Bio anuncia una presentación oral en EHA 2026 donde destacará el PMB-CT01 en linfomas de células B )

Also on site :

• The ‘imminent’ oil crisis isn’t at the pump—it’s under your hood
• Amazon’s 'Breathable' $15 Matching Cotton Lounge Set Is a 'Cute Summer Outfit' for Traveling and Running Errands
• Syd Announces New Album Beard, Shares New Song “Callin'”: Stream